These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 12032822)

  • 1. Dominant negative PDGF-C inhibits growth of Ewing family tumor cell lines.
    Zwerner JP; May WA
    Oncogene; 2002 May; 21(24):3847-54. PubMed ID: 12032822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors.
    Zwerner JP; May WA
    Oncogene; 2001 Feb; 20(5):626-33. PubMed ID: 11313995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. EWS/FLI function varies in different cellular backgrounds.
    Zwerner JP; Guimbellot J; May WA
    Exp Cell Res; 2003 Nov; 290(2):414-9. PubMed ID: 14567998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth factor PDGF-B/v-sis confers a tumorigenic phenotype to human tumor cells bearing PDGF receptors but not to cells devoid of receptors: evidence for an autocrine, but not a paracrine, mechanism.
    Potapova O; Fakhrai H; Mercola D
    Int J Cancer; 1996 May; 66(5):669-77. PubMed ID: 8647631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK; Schwartz DP; Mann E; Chen H; Tsai J; Chu L; Taylorson L; Longhi M; Meredith S; Germain L; Jacobs JS; Tang C; Ullrich A; Berens ME; Hersh E; McMahon G; Hirth KP; Powell TJ
    Clin Cancer Res; 1997 Jul; 3(7):1167-77. PubMed ID: 9815796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversion of autocrine transformation by a dominant negative platelet-derived growth factor mutant.
    Vassbotn FS; Andersson M; Westermark B; Heldin CH; Ostman A
    Mol Cell Biol; 1993 Jul; 13(7):4066-76. PubMed ID: 8321214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective platelet-derived growth factor receptor kinase blockers reverse sis-transformation.
    Kovalenko M; Gazit A; Böhmer A; Rorsman C; Rönnstrand L; Heldin CH; Waltenberger J; Böhmer FD; Levitzki A
    Cancer Res; 1994 Dec; 54(23):6106-14. PubMed ID: 7954456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional specificities of PDGF-C and PDGF-D, the novel members of the platelet-derived growth factors family.
    Reigstad LJ; Varhaug JE; Lillehaug JR
    FEBS J; 2005 Nov; 272(22):5723-41. PubMed ID: 16279938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dependence of autocrine growth factor stimulation in platelet-derived growth factor-B-induced mouse brain tumor cells.
    Uhrbom L; Hesselager G; Ostman A; Nistér M; Westermark B
    Int J Cancer; 2000 Feb; 85(3):398-406. PubMed ID: 10652433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
    Potapova O; Fakhrai H; Baird S; Mercola D
    Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. K252a inhibits proliferation of glioma cells by blocking platelet-derived growth factor signal transduction.
    Chin LS; Murray SF; Zitnay KM; Rami B
    Clin Cancer Res; 1997 May; 3(5):771-6. PubMed ID: 9815748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of platelet-derived growth factor-beta mRNA expression and cell growth in a human mesothelioma cell line by a hammerhead ribozyme.
    Dorai T; Kobayashi H; Holland JF; Ohnuma T
    Mol Pharmacol; 1994 Sep; 46(3):437-44. PubMed ID: 7935323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDGF-D is a potent transforming and angiogenic growth factor.
    Li H; Fredriksson L; Li X; Eriksson U
    Oncogene; 2003 Mar; 22(10):1501-10. PubMed ID: 12629513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDGF-D, a new protease-activated growth factor.
    LaRochelle WJ; Jeffers M; McDonald WF; Chillakuru RA; Giese NA; Lokker NA; Sullivan C; Boldog FL; Yang M; Vernet C; Burgess CE; Fernandes E; Deegler LL; Rittman B; Shimkets J; Shimkets RA; Rothberg JM; Lichenstein HS
    Nat Cell Biol; 2001 May; 3(5):517-21. PubMed ID: 11331882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated platelet-derived growth factor autocrine pathway drives the transformed phenotype of a human glioblastoma cell line.
    Vassbotn FS; Ostman A; Langeland N; Holmsen H; Westermark B; Heldin CH; Nistér M
    J Cell Physiol; 1994 Feb; 158(2):381-9. PubMed ID: 8106574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autocrine platelet-derived growth factor-dependent gene expression in glioblastoma cells is mediated largely by activation of the transcription factor sterol regulatory element binding protein and is associated with altered genotype and patient survival in human brain tumors.
    Ma D; Nutt CL; Shanehsaz P; Peng X; Louis DN; Kaetzel DM
    Cancer Res; 2005 Jul; 65(13):5523-34. PubMed ID: 15994924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The orphan nuclear receptor DAX1 is up-regulated by the EWS/FLI1 oncoprotein and is highly expressed in Ewing tumors.
    Mendiola M; Carrillo J; García E; Lalli E; Hernández T; de Alava E; Tirode F; Delattre O; García-Miguel P; López-Barea F; Pestaña A; Alonso J
    Int J Cancer; 2006 Mar; 118(6):1381-9. PubMed ID: 16206264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet derived growth factor/tyrosine kinase receptor mediated proliferation.
    Benito M; Lorenzo M
    Growth Regul; 1993 Sep; 3(3):172-9. PubMed ID: 8220110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of Stat5 by platelet-derived growth factor (PDGF) is dependent on phosphorylation sites in PDGF beta-receptor juxtamembrane and kinase insert domains.
    Valgeirsdóttir S; Paukku K; Silvennoinen O; Heldin CH; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(4):505-15. PubMed ID: 9484840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.